Key Insights

Highlights

Treatment Research

4 treatments under study, led by Normobaric Oxygen

Research Leaders

7 sponsors active, led by Kuopio University Hospital

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

33.3%

1 terminated out of 3 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
P 1 (1)

Trial Status

Recruiting1
Terminated1
Not Yet Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07890337Phase 1Recruiting

Rehabilitation Through Virtual Immersion & Integrated Exposure for Mild Traumatic Brain Injury (ReVIVE for mTBI)

NCT07702513Not ApplicableNot Yet Recruiting

A Pilot Study of Home-Based Rhythmic Auditory Stimulation to Evaluate Mobility, Balance, and Patient-Reported Outcomes After Traumatic Brain Injury

NCT01201291Not ApplicableTerminatedPrimary

Impact of Inspired Oxygen Fraction on Outcome in Patients With Traumatic Brain Injury

Showing all 3 trials

Research Network

Common Treatments

  • Normobaric Oxygen1
  • Standard Psychotherapy1
  • Homebased Rhythmic Auditory Stimulation1
  • Virtual Reality1

Active Sponsors

  • Kuopio University Hospital1
  • Turku University Hospital1
  • Helsinki University Central Hospital1
  • Craig Hospital1
  • Tampere University Hospital1

Related Conditions

  • Tbi Traumatic Brain Injury2
  • Tbi1
  • Traumatic Brain Injuries1
  • Mtbi Mild Traumatic Brain Injury1
  • Mtbi1

Activity Timeline